Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

PDF Research Advocates Highlight Unmet Needs in Parkinson’s at FDA Meeting

The Parkinson’s Disease Foundation (PDF) is pleased to report that five of its Research Advocates represented the community at last week’s Food and Drug Administration’s (FDA) Patient-Focused Drug Development meeting on Parkinson’s Disease in Silver Spring, MD.

The meeting was the first of its kind in the Parkinson’s community, providing the opportunity for people living with PD and care partners to share insights about life with the disease and those aspects that need more effective treatments.

PDF Research Advocates, along with other community representatives, helped to highlight symptoms and side effects for which there are few effective treatments. For example, Research Advocates focused on disabling nonmotor symptoms, such as pain and cognitive decline and secondary movement symptoms and complications such as dyskinesia and freezing. They also spoke about the need for medications that can provide a steadier therapeutic effect throughout the day.

The PDF Research Advocates who represented the community were:

  • Steve DeWitte, New Preston, CT, person living with PD
  • Todd Hebb, Towson, MD, person living with PD
  • Becky Houde, J.D., Waltham, MA, person living with PD
  • Rosa Kim, West Dundee, IL, former care partner to person with PD
  • Kevin Kwok, Pharm.D., San Francisco, CA, person living with PD

“After advocating for patient engagement in the Parkinson’s community for more than a decade, PDF applauds the FDA for hosting this meeting to gather the perspectives of people living with Parkinson’s disease. We thank our team of Research Advocates for helping to highlight unmet needs in Parkinson’s disease and advocate for more effective treatments,” said Veronica Todaro, M.P.H., Vice President, National Programs at PDF.

She later added in an interview with The Pink Sheet, “The meeting shines the light on the need to engage the people living [with] the disease early and often in the development of research priorities and therapies.”

Do you want to join PDF Research Advocates in sharing insights into life with Parkinson's? PDF, in collaboration with the Parkinson’s Action Network invites you to take the anonymous survey below about life with PD by Friday, October 30. Results will be shared with the FDA to help guide its work.

Tuesday, September 29, 2015
Parkinson’s Foundation Moving Day Walks Fund Local Parkinson’s Programs in Seven Cities for Spring 2018
Friday, February 16, 2018

NEW YORK & MIAMI, FEBRUARY 16, 2018 — The Parkinson’s Foundation is proud to announce that Moving Day, A Walk for Parkinson’s, has funded more than $17 million in mission services to make life better for people living with Parkinson’s disease (PD).

Terranova’s Stephen Bittel Donates $450,000 to Parkinson’s Foundation to Support Expansion of Centers of Excellence Network
Thursday, February 1, 2018

MIAMI – February 1, 2018 – The Parkinson’s Foundation today announced that Stephen Bittel, chairman and founder of Terranova, has made a $450,000 donation to support the expansion of the foundation’s Centers o

Largest Clinical Study of Parkinson’s Disease Reaches 10,000-Patient Milestone, Reveals Critical Learnings
Wednesday, January 10, 2018

NEW YORK & MIAMI - January 10, 2018 - The Parkinson’s Foundation today announced the enrollment of the 10,000th Parkinson’s patient and the discovery of critical new learnings in what represents the largest clinical study of Parkinson’s disease in history.

Parkinson's Foundation Mourns the Loss of Harold P. Kravitz and His Daughter, the Honorable Shelley J. Kravitz
Friday, January 5, 2018

Today we mourn the loss of two prominent figures in the history of the Parkinson's Foundation: Harold P. Kravitz, Esq. and his daughter, the Honorable Shelley J. Kravitz.

Parkinson's Foundation Mourns the Loss of Robert Burke, MD
Friday, January 5, 2018

The Parkinson’s Foundation mourns the loss of Robert Burke, MD, professor of Neurology at Columbia University, a Parkinson’s Foundation Center of Excellence. He was a former member of the Parkinson’s Disease Foundation (PDF) Scientific Advisory Board and led the PDF Research Center at Columbia.

Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.